Answers are grounded in this paper and cite their sources.
Analysis reveals distinct CD8+ T cell populations in Alzheimer’s disease mice, suggesting varied functions in disease progression.
In Alzheimer’s disease (AD), the involvement of CD8⁺ tissue-resident memory T cells (Trm) have attracted growing interest. During AD pathogenesis, age-associated and AD-associated CD8⁺ T cells may cooperatively influence disease progression; however, their phenotypic and functional differences remain poorly understood. Here, we reanalyzed public single-cell RNA sequencing datasets of brain-derived CD8⁺ T cells from normally aged, wild-type AD, and Cxcr6-deficient AD mice. We identified two major Trm populations: a C-X-C chemokine receptor type 6 (CXCR6)-related immunosuppressive cluster present in aged and wild-type AD mice, and an AD-associated cluster with stem-like features. These clusters were completely phenotypically and clonotypically distinct. Given the proposed role of CXCR6-related CD8⁺ T cells in reducing amyloid-β pathology, their presence in aged mice suggests a protective role. By contrast, the AD-associated cluster exhibited high Tcf7 and Bcl2 expression alongside upregulated immediate-early genes (IEGs), and showed strong clonal overlap with other IEG–enriched clusters. CellChat analysis revealed selective activation of the galectin-9-prolyl 4-hydroxylase pathway in AD-associated Trm-microglia interactions, implicating altered redox regulation. Structural modeling of expanded T cell receptors predicted stable binding to amyloid-β42 peptides, suggesting potential antigen specificity. These findings reveal two transcriptionally and clonotypically distinct CD8+ Trm populations with potentially opposing functions in AD.
No takes yet. Share an insight, caveat, or question.
Zhihuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: